These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
100 related articles for article (PubMed ID: 3073210)
21. [Changes in contractility parameters, coronary flow and myocardial oxygen consumption following intravenous diltiazem in patients with coronary heart disease]. Oeff M; Schröder R; Biamino G Z Kardiol; 1984 Nov; 73(11):717-23. PubMed ID: 6523970 [TBL] [Abstract][Full Text] [Related]
22. Diltiazem prevents hypertrophy progression, preserves systolic function, and normalises myocardial oxygen utilisation in the spontaneously hypertensive rat. Tubau JF; Wikman-Coffelt J; Massie BM; Szlachcic J; Parmley WW; Sievers R; Henderson S Cardiovasc Res; 1987 Aug; 21(8):606-14. PubMed ID: 2965615 [TBL] [Abstract][Full Text] [Related]
23. Discovery of novel and cardioselective diltiazem-like calcium channel blockers via virtual screening. Carosati E; Budriesi R; Ioan P; Ugenti MP; Frosini M; Fusi F; Corda G; Cosimelli B; Spinelli D; Chiarini A; Cruciani G J Med Chem; 2008 Sep; 51(18):5552-65. PubMed ID: 18754582 [TBL] [Abstract][Full Text] [Related]
24. Temperature-specific effects of adjuvant diltiazem therapy on myocardial energetics following potassium cardioplegic arrest. Krukenkamp IB; Silverman NA; Sorlie D; Pridjian A; Levitsky S Ann Thorac Surg; 1986 Dec; 42(6):675-80. PubMed ID: 3789858 [TBL] [Abstract][Full Text] [Related]
25. Hemodynamic and metabolic effects of diltiazem during coronary sinus pacing with particular reference to left ventricular ejection fraction. Josephson MA; Hopkins J; Singh BN Am J Cardiol; 1985 Feb; 55(4):286-90. PubMed ID: 3969863 [TBL] [Abstract][Full Text] [Related]
26. Influence of diltiazem on cardiovascular function and coronary hemodynamics during isoflurane anesthesia in the dog: correlation with plasma diltiazem levels. Kapur PA; Campos JH; Tippit SE Anesth Analg; 1986 Jan; 65(1):81-7. PubMed ID: 3940473 [TBL] [Abstract][Full Text] [Related]
27. A comparison of an A1 adenosine receptor agonist (CVT-510) with diltiazem for slowing of AV nodal conduction in guinea-pig. Snowdy S; Liang HX; Blackburn B; Lum R; Nelson M; Wang L; Pfister J; Sharma BP; Wolff A; Belardinelli L Br J Pharmacol; 1999 Jan; 126(1):137-46. PubMed ID: 10051130 [TBL] [Abstract][Full Text] [Related]
28. Chronotropic, inotropic, and vasodilator actions of diltiazem, nifedipine, and verapamil. A comparative study of physiological responses and membrane receptor activity. Millard RW; Grupp G; Grupp IL; DiSalvo J; DePover A; Schwartz A Circ Res; 1983 Feb; 52(2 Pt 2):I29-39. PubMed ID: 6831652 [TBL] [Abstract][Full Text] [Related]
30. Myocardial perfusion distal to an acute or chronic coronary artery occlusion: effects of diltiazem and nifedipine. Zyvoloski MG; Brooks HL; Gross GJ; Warltier DC J Pharmacol Exp Ther; 1982 Aug; 222(2):494-500. PubMed ID: 7097568 [TBL] [Abstract][Full Text] [Related]
31. Protective effects of diltiazem during myocardial ischemia in isolated cat hearts. Bush LR; Li YP; Shlafer M; Jolly SR; Lucchesi BR J Pharmacol Exp Ther; 1981 Sep; 218(3):653-61. PubMed ID: 7264949 [TBL] [Abstract][Full Text] [Related]
32. Systemic, left ventricular and coronary hemodynamic effects of intravenous diltiazem in coronary artery disease. Joyal M; Cremer KF; Pieper JA; Feldman RL; Pepine CJ Am J Cardiol; 1985 Sep; 56(7):413-7. PubMed ID: 4036821 [TBL] [Abstract][Full Text] [Related]
33. Cardiac action of KB-944, a new calcium antagonist. Morita T; Ito K; Nose T Arzneimittelforschung; 1982; 32(9):1053-5. PubMed ID: 6890825 [TBL] [Abstract][Full Text] [Related]
34. Collateral blood flow following acute coronary artery occlusion: comparison of a new intracellular calcium antagonist (KT-362) and diltiazem. Farber NE; Gross GJ J Cardiovasc Pharmacol; 1989 Jul; 14(1):66-72. PubMed ID: 2475718 [TBL] [Abstract][Full Text] [Related]
36. Combined effects of benidipine and diltiazem on cardiohemodynamics in anesthetized dogs. Yao K; Maeda H; Ina Y; Sato M; Fujita K; Kuwabara T; Kobayashi H; Shirakura S Biol Pharm Bull; 2006 Apr; 29(4):730-4. PubMed ID: 16595908 [TBL] [Abstract][Full Text] [Related]
37. Cardioplegic arrest of the myocardium with calcium blocking agents. Balderman SC; Schwartz K; Aldrich J; Chan AK J Cardiovasc Pharmacol; 1992 Jan; 19(1):1-9. PubMed ID: 1375673 [TBL] [Abstract][Full Text] [Related]
38. Myocardial reoxygenation damage. Can it be circumvented? Chappell SP; Lewis MJ; Henderson AH Adv Myocardiol; 1985; 6():585-92. PubMed ID: 3992051 [TBL] [Abstract][Full Text] [Related]
39. Mechanism(s) of calcium antagonists and ischemia. Hugenholtz PG; de Jong JW Z Kardiol; 1984; 73 Suppl 2():89-93. PubMed ID: 6528706 [TBL] [Abstract][Full Text] [Related]
40. Potent antifibrillatory effect of combined blockade of calcium channels and 5-HT2 receptors with nexopamil during myocardial ischemia and reperfusion in dogs: comparison to diltiazem. Nearing BD; Hutter JJ; Verrier RL J Cardiovasc Pharmacol; 1996 Jun; 27(6):777-87. PubMed ID: 8761843 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]